Identification, antimicrobial resistance profiles, and virulence of members from the family Enterobacteriaceae from the feces of yellow-headed blackbirds (Xanthocephalus xanthocephalus) in North Dakota.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 17992921)

Published in Avian Dis on September 01, 2007

Authors

Penelope S Gibbs1, Rachel Kasa, Jennifer L Newbrey, Shana R Petermann, Richard E Wooley, Heather M Vinson, Wendy Reed

Author Affiliations

1: Department of Veterinary and Microbiological Sciences, College of Agriculture, Food Systems, and Natural Resources, North Dakota State University, Fargo, ND 58105, USA. penelope.gibbs@ndsu.edu

Articles by these authors

Location of increased serum survival gene and selected virulence traits on a conjugative R plasmid in an avian Escherichia coli isolate. Avian Dis (2002) 1.13

Characterizing avian Escherichia coli isolates with multiplex polymerase chain reaction. Avian Dis (2004) 1.00

Molecular and comparative analysis of Salmonella enterica Senftenberg from humans and animals using PFGE, MLST and NARMS. BMC Microbiol (2011) 0.97

Development and evaluation of an experimental model of cutaneous columnaris disease in koi Cyprinus carpio. J Vet Diagn Invest (2005) 0.85

Prediction of chicken embryo lethality with the avian Escherichia coli traits complement resistance, colicin V production, and presence of the increased serum survival gene cluster (iss). Avian Dis (2003) 0.85

Comparison of several challenge models for studies in avian colibacillosis. Avian Dis (2004) 0.84

Complement resistance, as determined by viable count and flow cytometric methods, and its association with the presence of iss and the virulence of avian Escherichia coli. Avian Dis (2002) 0.81

In vitro and in vivo evaluation of a potentiated miconazole aural solution in chronic Malassezia otitis externa in dogs. Vet Dermatol (2009) 0.79

Comparison of the intravenous chicken challenge method with the embryo lethality assay for studies in avian colibacillosis. Avian Dis (2003) 0.79

In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis. Am J Vet Res (2006) 0.75

Virulence factors associated with Escherichia coli present in a commercially produced competitive exclusion product. Avian Dis (2002) 0.75

Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro. Vet Ther (2002) 0.75

Use of potentiated antibiotics in wound management. Vet Clin North Am Exot Anim Pract (2004) 0.75

Proteomic analysis of multidrug resistant Escherichia coli strains from scouring calves. Vet Microbiol (2011) 0.75